GLP-1 drugs are glucose-dependent
Baseline Characteristics of Patients in Each Type 2 Diabetes Drug Exposure Cohort (Semaglutide, Dulaglutide, Exenatide, Empagliflozin, Sitagliptin, Glipizide) During the Study Period in the Optums Deidentified Clinformatics Data Mart Database (Clinformatics)
Oral semaglutide (and other medications which work in a similar way) reduces the risk of heart and circulatory problems, such as heart attacks and strokes, in people who already have one of these conditions or are at very high risk because of other health problems
When the Brain Feels Clouded This inflammation affects neurotransmitter neural signalling as well as balance
Studies and clinical trials show that when people stop taking GLP-1s, the appetite often comes back, and in many cases there is rapid weight regain, especially if nutrition and behavior changes werent made when on the medication, she says